Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II

Joshua A. Beckman; Francesco Paneni; Francesco Cosentino; Mark A. Creager

doi:10.1093/eurheartj/eht142

Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II

Joshua A. Beckman, Francesco Paneni, Francesco Cosentino, Mark A. Creager

Research output: Contribution to journal › Review article › peer-review

276 Scopus citations

Abstract

In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.

Original language	English (US)
Pages (from-to)	2444-2456
Number of pages	13
Journal	European heart journal
Volume	34
Issue number	31
DOIs	https://doi.org/10.1093/eurheartj/eht142
State	Published - Aug 14 2013
Externally published	Yes

Keywords

Diabetes
Medical therapy
Vascular disease

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1093/eurheartj/eht142

Cite this

@article{1fd762b7cdef40038d732eccda4e5bda,

title = "Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II",

abstract = "In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.",

keywords = "Diabetes, Medical therapy, Vascular disease",

author = "Beckman, {Joshua A.} and Francesco Paneni and Francesco Cosentino and Creager, {Mark A.}",

year = "2013",

month = aug,

day = "14",

doi = "10.1093/eurheartj/eht142",

language = "English (US)",

volume = "34",

pages = "2444--2456",

journal = "European heart journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "31",

}

TY - JOUR

T1 - Diabetes and vascular disease

T2 - Pathophysiology, clinical consequences, and medical therapy: Part II

AU - Beckman, Joshua A.

AU - Paneni, Francesco

AU - Cosentino, Francesco

AU - Creager, Mark A.

PY - 2013/8/14

Y1 - 2013/8/14

N2 - In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.

AB - In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.

KW - Diabetes

KW - Medical therapy

KW - Vascular disease

UR - http://www.scopus.com/inward/record.url?scp=84882354610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882354610&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/eht142

DO - 10.1093/eurheartj/eht142

M3 - Review article

C2 - 23625211

AN - SCOPUS:84882354610

SN - 0195-668X

VL - 34

SP - 2444

EP - 2456

JO - European heart journal

JF - European heart journal

IS - 31

ER -

Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this